FCM Investments TX reduced its stake in shares of Healthequity Inc (NASDAQ:HQY) by 9.5% in the 4th quarter, Holdings Channel reports. The firm owned 65,887 shares of the company’s stock after selling 6,944 shares during the quarter. Healthequity accounts for 4.4% of FCM Investments TX’s investment portfolio, making the stock its 9th largest holding. FCM Investments TX’s holdings in Healthequity were worth $3,074,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Zions Bancorporation bought a new position in shares of Healthequity in the 3rd quarter worth about $119,000. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Healthequity by 105.8% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,544 shares of the company’s stock worth $127,000 after acquiring an additional 1,308 shares in the last quarter. Riverhead Capital Management LLC raised its position in shares of Healthequity by 75.3% in the 2nd quarter. Riverhead Capital Management LLC now owns 2,629 shares of the company’s stock worth $131,000 after acquiring an additional 1,129 shares in the last quarter. Oppenheimer Asset Management Inc. raised its position in shares of Healthequity by 7.7% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 2,686 shares of the company’s stock worth $134,000 after acquiring an additional 191 shares in the last quarter. Finally, D.A. Davidson & CO. raised its position in shares of Healthequity by 15.2% in the 2nd quarter. D.A. Davidson & CO. now owns 3,326 shares of the company’s stock worth $165,000 after acquiring an additional 439 shares in the last quarter. 98.25% of the stock is owned by institutional investors and hedge funds.

Shares of Healthequity Inc (NASDAQ HQY) traded up $0.16 during midday trading on Wednesday, hitting $49.08. The stock had a trading volume of 366,300 shares, compared to its average volume of 435,610. Healthequity Inc has a 12-month low of $37.62 and a 12-month high of $55.31. The stock has a market cap of $2,968.10, a P/E ratio of 66.32, a PEG ratio of 2.02 and a beta of 1.74.

Healthequity (NASDAQ:HQY) last announced its earnings results on Tuesday, December 5th. The company reported $0.17 earnings per share for the quarter, topping analysts’ consensus estimates of $0.13 by $0.04. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The firm had revenue of $56.80 million for the quarter, compared to the consensus estimate of $55.27 million. During the same quarter in the previous year, the business earned $0.10 EPS. The company’s revenue was up 31.0% compared to the same quarter last year. research analysts anticipate that Healthequity Inc will post 0.71 earnings per share for the current year.

In other Healthequity news, EVP Delano Ladd sold 26,405 shares of the business’s stock in a transaction on Tuesday, December 12th. The shares were sold at an average price of $43.32, for a total transaction of $1,143,864.60. Following the sale, the executive vice president now owns 16,692 shares of the company’s stock, valued at approximately $723,097.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Darcy G. Mott sold 9,500 shares of the business’s stock in a transaction on Friday, October 20th. The shares were sold at an average price of $49.90, for a total transaction of $474,050.00. Following the sale, the vice president now directly owns 90,500 shares in the company, valued at approximately $4,515,950. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,116,434 shares of company stock worth $58,417,878. 19.00% of the stock is owned by company insiders.

A number of analysts recently commented on the company. BidaskClub raised Healthequity from a “sell” rating to a “hold” rating in a research report on Thursday, September 28th. Zacks Investment Research upgraded Healthequity from a “hold” rating to a “buy” rating and set a $58.00 price target for the company in a research note on Wednesday, October 11th. Cantor Fitzgerald reiterated a “buy” rating and set a $56.00 price target on shares of Healthequity in a research note on Monday, September 25th. Robert W. Baird reiterated a “hold” rating on shares of Healthequity in a research note on Thursday, September 21st. Finally, Citigroup initiated coverage on Healthequity in a research note on Thursday, January 4th. They set a “buy” rating for the company. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $58.33.

ILLEGAL ACTIVITY WARNING: This piece was reported by Watch List News and is owned by of Watch List News. If you are reading this piece on another publication, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be viewed at https://www.watchlistnews.com/fcm-investments-tx-sells-6944-shares-of-healthequity-inc-hqy/1810900.html.

About Healthequity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).

Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.